---
figid: PMC9428582__fonc-12-960312-g002
figtitle: Targeting O-GlcNAcylation to overcome resistance to anti-cancer therapies
organisms:
- NA
pmcid: PMC9428582
filename: fonc-12-960312-g002.jpg
figlink: /pmc/articles/PMC9428582/figure/f2/
number: F2
caption: O-GlcNAcylation and anti-cancer chemotherapies. O-GlcNAcylation modulates
  cancer cell response to 5-FU, cisplatin, gemcitabine, doxorubicin and erastin/RSL3
  chemotherapies. Green and red arrows indicate respectively activation and inhibition
  of protein targeted by O-GlcNAcylation. The gray color indicates that the protein
  is inactivated/absent or that the cellular mechanism is not taking place.5-FU, 5-fluorouracil;
  BiP, Binding immunoglobulin Protein; CDDP, cis-diaminedichloroplatinium(II); CHOP,
  C/EBP Homologous Protein; CLU, Clusterin; dUMP, deoxyuridine monophosphate; dT,
  deoxythymidine; dTMP, dT monophosphate; EGFR, Epidermal Growth Factor Receptor;
  ER, endoplasmic reticulum; FBL, Fibrillarin; FTH1, Ferritin Heavy chain 1; FdUMP,
  fluorodUMP; FUdR, fluorodeoxyuridine; HBP, Hexosamine Biosynthetic Pathway; HCF-1,
  Host Cell Factor-1; HMOX1, Heme Oxygenase-1; HO-1, Heme Oxygenase-1; HSP27, Heat
  Shock Protein 27 kD; IRE1α, Inositol-Requiring Enzyme 1α; NF-κB, Nuclear Factor-Kappa
  B; NRF2, Nuclear factor erythroid-2-Related Factor 2; OGT, O-GlcNAc Transferase;
  PERK, Protein kinase RNA-like Kinase; PGM3, Phosphoacetylglucosamine Mutase 3; PI3K,
  Phosphatidylinositol 3-Kinase; Polη, DNA Polymerase η; pVHL, von Hippel-Lindau protein;
  ROS, reactive oxygen species; RSL3, Ras-selective lethal small molecule 3; sCLU,
  secretory CLU; SLC29A1, Solute Carrier family 29 member 1; SNAP, Synaptosomal Associated
  Protein; SNARE, Soluble N-ethylmaleimide-sensitive-factor Attachment protein Receptor;
  TET1, Tet methylcytosine dioxygenase 1; TfR1, Transferrin Receptor 1; TFRC, Transferrin
  Receptor; Thr, threonine; TK, Thymidine Kinase; TLS, translesion DNA synthesis;
  TP, Thymidine Phosphorylase; TS, Thymidylate Synthase; UDP-GlcNAc, uridine disphosphate
  N-acetylglucosamine; UPR, unfolded protein response; XBP, AKT/X-Box Binding Protein;
  YAP, Yes-Associated Protein.
papertitle: Targeting O-GlcNAcylation to overcome resistance to anti-cancer therapies.
reftext: Ninon Very, et al. Front Oncol. 2022;12:960312.
year: '2022'
doi: 10.3389/fonc.2022.960312
journal_title: Frontiers in Oncology
journal_nlm_ta: Front Oncol
publisher_name: Frontiers Media S.A.
keywords: 6845/12000 O-GlcNAcylation | cancer | therapy resistance | therapeutic strategy
  | post-translational modifications (PTMs)
automl_pathway: 0.9247196
figid_alias: PMC9428582__F2
figtype: Figure
organisms_ner:
- Drosophila melanogaster
- Homo sapiens
redirect_from: /figures/PMC9428582__F2
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC9428582__fonc-12-960312-g002.html
  '@type': Dataset
  description: O-GlcNAcylation and anti-cancer chemotherapies. O-GlcNAcylation modulates
    cancer cell response to 5-FU, cisplatin, gemcitabine, doxorubicin and erastin/RSL3
    chemotherapies. Green and red arrows indicate respectively activation and inhibition
    of protein targeted by O-GlcNAcylation. The gray color indicates that the protein
    is inactivated/absent or that the cellular mechanism is not taking place.5-FU,
    5-fluorouracil; BiP, Binding immunoglobulin Protein; CDDP, cis-diaminedichloroplatinium(II);
    CHOP, C/EBP Homologous Protein; CLU, Clusterin; dUMP, deoxyuridine monophosphate;
    dT, deoxythymidine; dTMP, dT monophosphate; EGFR, Epidermal Growth Factor Receptor;
    ER, endoplasmic reticulum; FBL, Fibrillarin; FTH1, Ferritin Heavy chain 1; FdUMP,
    fluorodUMP; FUdR, fluorodeoxyuridine; HBP, Hexosamine Biosynthetic Pathway; HCF-1,
    Host Cell Factor-1; HMOX1, Heme Oxygenase-1; HO-1, Heme Oxygenase-1; HSP27, Heat
    Shock Protein 27 kD; IRE1α, Inositol-Requiring Enzyme 1α; NF-κB, Nuclear Factor-Kappa
    B; NRF2, Nuclear factor erythroid-2-Related Factor 2; OGT, O-GlcNAc Transferase;
    PERK, Protein kinase RNA-like Kinase; PGM3, Phosphoacetylglucosamine Mutase 3;
    PI3K, Phosphatidylinositol 3-Kinase; Polη, DNA Polymerase η; pVHL, von Hippel-Lindau
    protein; ROS, reactive oxygen species; RSL3, Ras-selective lethal small molecule
    3; sCLU, secretory CLU; SLC29A1, Solute Carrier family 29 member 1; SNAP, Synaptosomal
    Associated Protein; SNARE, Soluble N-ethylmaleimide-sensitive-factor Attachment
    protein Receptor; TET1, Tet methylcytosine dioxygenase 1; TfR1, Transferrin Receptor
    1; TFRC, Transferrin Receptor; Thr, threonine; TK, Thymidine Kinase; TLS, translesion
    DNA synthesis; TP, Thymidine Phosphorylase; TS, Thymidylate Synthase; UDP-GlcNAc,
    uridine disphosphate N-acetylglucosamine; UPR, unfolded protein response; XBP,
    AKT/X-Box Binding Protein; YAP, Yes-Associated Protein.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - fbl
  - sxc
  - yki
  - Hcf
  - Keap1
  - cnc
  - Akt
  - Smox
  - Ts
  - Dt
  - PEK
  - rl
  - Ho
  - Dif
  - dl
  - Rel
  - CkIIbeta
  - Andorra
  - Anp
  - Acam
  - alphaSnap
  - p53
  - betaTub60D
  - hth
  - Myc
  - nst
  - Hsp27
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - Egfr
  - clu
  - ab
  - bip
  - Hsc70-3
  - FBL
  - OGT
  - EOGT
  - POMGNT1
  - POMGNT2
  - YAP1
  - TFRC
  - HCFC1
  - GABPA
  - NFE2L2
  - AKT1
  - AKT2
  - AKT3
  - XBP1P1
  - FTH1
  - HMOX1
  - EMP1
  - EIF2AK3
  - DDIT3
  - SLC29A1
  - NFKB1
  - VHL
  - SNAP25
  - SNAR-E
  - TP53
  - TP63
  - TP73
  - MYC
  - PGM3
  - FUS
  - HSPB1
  - HSPB2
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - EGFR
  - CLU
  - GDF10
  - HSPA5
  - AZU1
  - HDLBP
  - SLBP
  - STAM2
  - HEBP1
---
